NO984740L - Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler - Google Patents

Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler

Info

Publication number
NO984740L
NO984740L NO984740A NO984740A NO984740L NO 984740 L NO984740 L NO 984740L NO 984740 A NO984740 A NO 984740A NO 984740 A NO984740 A NO 984740A NO 984740 L NO984740 L NO 984740L
Authority
NO
Norway
Prior art keywords
analgesics
compounds
acetylcholinesterase inhibitors
isatin derivatives
isatin
Prior art date
Application number
NO984740A
Other languages
English (en)
Other versions
NO984740D0 (no
Inventor
Stephen James Shimshock
Abdul Ezaz Mutlib
Susan Marie Chesson
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO984740D0 publication Critical patent/NO984740D0/no
Publication of NO984740L publication Critical patent/NO984740L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Foreliggende søknad angår forbindelser av formel (I) (D hvori R, X og Y er som definert, hvilke forbindelser er anvendbare for behand- ling av hukommelsesdysfunksjon som er karakterisert ved redusert cholinerg funksjon, og for analgesi, farmasøyt- iske preparater inneholdende forbindel- sene og metoder for fremstilling og anvendelse av forbindelsene.
NO984740A 1996-04-12 1998-10-09 Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler NO984740L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63187096A 1996-04-12 1996-04-12
PCT/US1997/003598 WO1997038993A1 (en) 1996-04-12 1997-03-07 Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Publications (2)

Publication Number Publication Date
NO984740D0 NO984740D0 (no) 1998-10-09
NO984740L true NO984740L (no) 1998-10-09

Family

ID=24533114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984740A NO984740L (no) 1996-04-12 1998-10-09 Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler

Country Status (19)

Country Link
EP (1) EP0892796B1 (no)
JP (1) JP4109718B2 (no)
KR (1) KR20000005379A (no)
CN (1) CN1215399A (no)
AR (1) AR006606A1 (no)
AT (1) ATE207483T1 (no)
BR (1) BR9708655A (no)
CA (1) CA2252039C (no)
DE (1) DE69707659T2 (no)
DK (1) DK0892796T3 (no)
ES (1) ES2165586T3 (no)
GR (1) GR3037006T3 (no)
HU (1) HUP9903473A3 (no)
IL (1) IL126308A0 (no)
NO (1) NO984740L (no)
PT (1) PT892796E (no)
TW (1) TW426678B (no)
WO (1) WO1997038993A1 (no)
ZA (1) ZA972990B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
EA202092673A3 (ru) 2010-02-09 2021-05-31 Дзе Джонс Хопкинс Юниверсити Способы и композиции для улучшения когнитивной функции
MX2012008721A (es) 2010-02-16 2012-08-17 Pfizer (r)-4-((4-((4-(tetrahidrofuran-3-iloxi)benzo[d]isoxazol-3-iloxi)m etil) tetrahidro-2h-piran-4-ol, un agonista pacial de receptores 5-ht4.
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
GEP201706739B (en) 2012-12-13 2017-09-25 H Lundbeck As Compositions comprising vortioxetine and donepezil
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
US10537552B2 (en) 2015-05-05 2020-01-21 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
CA2986598C (en) 2015-05-22 2023-09-26 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
US20250032476A1 (en) * 2021-11-05 2025-01-30 The Regents Of The University Of California Alpha-2a adrenergic receptor modulators and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
GR3037006T3 (en) 2002-01-31
HUP9903473A2 (hu) 2000-05-28
NO984740D0 (no) 1998-10-09
KR20000005379A (en) 2000-01-25
WO1997038993A1 (en) 1997-10-23
DE69707659T2 (de) 2002-05-08
ATE207483T1 (de) 2001-11-15
DE69707659D1 (de) 2001-11-29
AU716997B2 (en) 2000-03-16
EP0892796B1 (en) 2001-10-24
PT892796E (pt) 2002-03-28
ZA972990B (en) 1997-11-03
CA2252039A1 (en) 1997-10-23
DK0892796T3 (da) 2001-11-19
AR006606A1 (es) 1999-09-08
JP4109718B2 (ja) 2008-07-02
CN1215399A (zh) 1999-04-28
CA2252039C (en) 2002-12-24
HUP9903473A3 (en) 2000-09-28
BR9708655A (pt) 1999-08-03
ES2165586T3 (es) 2002-03-16
TW426678B (en) 2001-03-21
JP2001508400A (ja) 2001-06-26
AU2072597A (en) 1997-11-07
IL126308A0 (en) 1999-05-09
EP0892796A1 (en) 1999-01-27

Similar Documents

Publication Publication Date Title
NO984740L (no) Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler
MX9702865A (es) Agentes estrogenicos.
RU94044677A (ru) Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
BG106340A (en) Substituted oxoazaheterocyclyl compounds
RU94036448A (ru) Производные галантамина и фармацевтическая композиция
WO2002046170A8 (en) Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
AU2019502A (en) Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
NO20005715D0 (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
BR0007589A (pt) Inibidores da proliferação de células
NZ312840A (en) Ketoheterocyclic inhibitors of factor Xa
NO996108L (no) 9-oksinerytromycinderivater
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
NO990896L (no) Bidentate metalloproteaseinhibitorer
WO2001072708A3 (en) OXINDOLE INHIBITORS OF FACTOR Xa
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
EG20726A (en) Process for preparing of galanthamine derivatives as acetylchol inc-sterase inhibitors
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
NO975681L (no) Benzisoxazol- og indazol-derivater som antipsykotiske midler
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
CA2374643A1 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists